Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Gains from Sales and Divestitures (2016)

Historic Gains from Sales and Divestitures for Fresenius Medical Care AG (FMS) over the last 1 years, with Q4 2016 value amounting to $5.3 million.

  • Fresenius Medical Care AG's Gains from Sales and Divestitures changed N/A to $5.3 million in Q4 2016 from the same period last year, while for Dec 2016 it was $5.3 million, marking a year-over-year change of. This contributed to the annual value of $5.3 million for FY2016, which is N/A changed from last year.
  • Latest data reveals that Fresenius Medical Care AG reported Gains from Sales and Divestitures of $5.3 million as of Q4 2016.
  • In the past 5 years, Fresenius Medical Care AG's Gains from Sales and Divestitures registered a high of $5.3 million during Q4 2016, and its lowest value of $5.3 million during Q4 2016.